387 related articles for article (PubMed ID: 8550066)
21. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1.
Chu ET; Lareau M; Rosenwasser LJ; Dinarello CA; Geha RS
J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918
[TBL] [Abstract][Full Text] [Related]
22. Induction of anergy in CD8 T cells by B cell presentation of antigen.
Höllsberg P; Batra V; Dressel A; Hafler DA
J Immunol; 1996 Dec; 157(12):5269-76. PubMed ID: 8955172
[TBL] [Abstract][Full Text] [Related]
23. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
Clement LT; Tedder TF; Gartland GL
J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
[TBL] [Abstract][Full Text] [Related]
24. Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells.
Scheinecker C; Machold KP; Majdic O; Höcker P; Knapp W; Smolen JS
J Immunol; 1998 Oct; 161(8):3966-73. PubMed ID: 9780165
[TBL] [Abstract][Full Text] [Related]
25. Induction of tolerance in freshly isolated alloreactive T cells by activated T cell stimulators is not due to the absence of CD28-B7 interaction.
Satyaraj E; Rath S; Bal V
J Immunol; 1995 Nov; 155(10):4669-75. PubMed ID: 7594466
[TBL] [Abstract][Full Text] [Related]
26. Differential effect of anti-B7-1 and anti-M150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages.
Agrewala JN; Suvas S; Verma RK; Mishra GC
J Immunol; 1998 Feb; 160(3):1067-77. PubMed ID: 9570518
[TBL] [Abstract][Full Text] [Related]
27. B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation.
Sansom DM; Wilson A; Boshell M; Lewis J; Hall ND
Immunology; 1993 Oct; 80(2):242-7. PubMed ID: 7505258
[TBL] [Abstract][Full Text] [Related]
28. Activated T hybridomas induce upregulation of B7-1 on bystander B lymphoma cells by a contact-dependent interaction utilizing CD40 ligand.
Jones KW; Hackett CJ
Cell Immunol; 1996 Nov; 174(1):42-53. PubMed ID: 8929453
[TBL] [Abstract][Full Text] [Related]
29. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression.
Nabavi N; Freeman GJ; Gault A; Godfrey D; Nadler LM; Glimcher LH
Nature; 1992 Nov; 360(6401):266-8. PubMed ID: 1279442
[TBL] [Abstract][Full Text] [Related]
30. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
Kleindienst P; Brocker T
Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
[TBL] [Abstract][Full Text] [Related]
31. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
[TBL] [Abstract][Full Text] [Related]
32. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
[TBL] [Abstract][Full Text] [Related]
33. Noncytotoxic human CD4+ T-cell clones presenting and simultaneously responding to an antigen die of apoptosis.
Bettens F; Frei E; Frutig K; Mauri D; Pichler WJ; Wyss-Coray T
Cell Immunol; 1995 Mar; 161(1):72-8. PubMed ID: 7532549
[TBL] [Abstract][Full Text] [Related]
34. Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro.
Murray AG; Libby P; Pober JS
J Immunol; 1995 Jan; 154(1):151-61. PubMed ID: 7995934
[TBL] [Abstract][Full Text] [Related]
35. Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help.
Chirmule N; Wang XP; Hu R; Oyaizu N; Roifman C; Pahwa R; Kalyanaraman VS; Pahwa S
Cell Immunol; 1994 Apr; 155(1):169-82. PubMed ID: 8168144
[TBL] [Abstract][Full Text] [Related]
36. Transfection of B7-1 cDNA empowers antigen presentation of blood malignant cells for activation of anti-tumor T cells.
Ke X; Jia L; Wang J; Wang D
Chin Med J (Engl); 2003 Jan; 116(1):78-84. PubMed ID: 12667394
[TBL] [Abstract][Full Text] [Related]
37. Superantigens initiate cognate CD4+ T cell/B cell interactions leading to early activation and proliferation of B cells.
al-Daccak R; Damaj B; Naccache PH; Mourad W
Eur J Immunol; 1995 Sep; 25(9):2539-43. PubMed ID: 7589123
[TBL] [Abstract][Full Text] [Related]
38. Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells.
Marelli-Berg FM; Weetman A; Frasca L; Deacock SJ; Imami N; Lombardi G; Lechler RI
J Immunol; 1997 Dec; 159(12):5853-61. PubMed ID: 9550381
[TBL] [Abstract][Full Text] [Related]
39. B7, a B-cell-restricted antigen that identifies preactivated B cells.
Freedman AS; Freeman G; Horowitz JC; Daley J; Nadler LM
J Immunol; 1987 Nov; 139(10):3260-7. PubMed ID: 3500211
[TBL] [Abstract][Full Text] [Related]
40. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
